Marijuana-induced myocarditis in a 24-year-old man
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
Abstract
##plugins.themes.bootstrap3.article.details##
marijuana abuse, myocarditis, cannabis
2. Suerken CK, Reboussin BA, Sutfin EL, Wagoner KG, Spangler J, Wolfson M. Prevalence of marijuana use at college entry and risk factors for initiation during freshman year. Addict Behav. 2014; 39(1):302-307. doi: 10.1016/j.addbeh.2013.10.018
3. Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014; 370(23):2219-2227. doi: 10.1056/NEJMra1402309
4. Amar MB. Cannabinoids in medicine: A review of their therapeutic potential. J Ethnopharmacol. 2006; 105(1-2):1-25. doi: 10.1016/j.jep.2006.02.001
5. McLaren J, Swift W, Dillon P, Allsop S. Cannabis potency and contamination: a review of the literature. Addiction. 2008; 103(7):1100-1109. doi: 10.1111/j.1360-0443.2008.02230.x
6. Mach F, Montecucco F, Steffens S. Cannabinoid receptors in acute and chronic complications of atherosclerosis. Br J Pharmacol. 2008; 153(2):290-298.
7. Kattoor A, Mehta J: Marijuana and coronary heart disease. American College of Cardiology [https://www.acc.org/latest-in-cardiology/articles/2016/09/22/08/58/marijuana-and-coronary-heart-disease available at 06/20/2022]
8. Feldman AM, McNamara D. Myocarditis. N Engl J Med. 2000; 343(19):1388-1398. doi: 10.1056/NEJM200011093431908
9. Fabre A, Sheppard MN. Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death. Heart. 2006; 92(3):316-320. doi: 10.1136/hrt.2004.045518
10. Kariyanna PT, Jayarangaiah A, Singh N, et al. Marijuana induced myocarditis: a new entity of toxic myocarditis. Am J Med Case Rep. 2018; 6(9):169-172. doi: 10.12691/ajmcr-6-9-1
11. Leontiadis E, Morshuis M, Arusoglu L, Cobaugh D, Koerfer R, El-Banayosy A. Thoratec left ventricular assist device removal after toxic myocarditis. Ann Thorac Surg. 2008; 86(6):1982-1985. doi: 10.1016/j.athoracsur.2008.04.092
12. Rodríguez-Castro CE, Alkhateeb H, Elfar A, Saifuddin F, Abbas A, Siddiqui T. Recurrent myopericarditis as a complication of marijuana use. Am J Case Rep. 2014; 15:60-62. doi: 10.12659/AJCR.889808
13. Tournebize J, Gibaja V, Puskarczyk E, Popovic B, Kahn J-P. Myocarditis and cannabis: An unusual association. Toxicol Anal Clin. 2016; 28(3):236. doi: 10.1016/j.toxac.2016.05.005
14. Nappe TM, Hoyte CO. Pediatric death due to myocarditis after exposure to cannabis. Clin Pract Cases Emerg Med. 2017; 1(3):166-170. doi: 10.5811/cpcem.2017.1.33240
15. Yamamoto I, Watanabe K, Matsunaga T, Kimura T, Funahashi T, Yoshimura H. Pharmacology and toxicology of major constituents of marijuana—on the metabolic activation of cannabinoids and its mechanism. Toxin Rev. 2003; 22(4):577-589. doi: 10.1081/TXR-120026915
16. Franz CA, Frishman WH. Marijuana use and cardiovascular disease. Cardiol Rev. 2016; 24(4):158-162. doi: 10.1097/CRD.0000000000000103
17. Tso M, Kushneriuk DJ, Bree TL, Nosib SS. Incidental acute ST elevation due to cannabis-induced myocarditis after a mechanical fall. CJC Open. 2021; 3(10):1303-1306. doi: 10.1016/j.cjco.2021.05.008
18. Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation. 2006; 113(6):876-890. doi: 10.1161/CIRCULATIONAHA.105.584532
19. Smith SC, Ladenson JH, Mason JW, Jaffe AS. Elevations of cardiac troponin I associated with myocarditis: experimental and clinical correlates. Circulation. 1997; 95(1):163-168. PMID: 8994432.
20. Nishii M, Inomata T, Takehana H, et al. Serum levels of interleukin-10 on admission as a prognostic predictor of human fulminant myocarditis. J Am Coll Cardiol. 2004; 44(6):1292-1297. doi: 10.1016/j.jacc.2004.01.055
Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.
Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.
Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.